Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(13 sites)
United States
Orthopedic Institute for Children- Site Number : 8400009, Los Angeles, California Innovative Hematology, Inc.- Site Number : 8400006, Indianapolis, Indiana University of Iowa- Site Number : 8400004, Iowa City, Iowa Ohio State University Hospital East- Site Number : 8400001, Columbus, Ohio Canada
Investigational Site Number : 1240003, Hamilton, Ontario Investigational Site Number : 1240004, Hamilton, Ontario Japan
Investigational Site Number : 3920003, Kawasaki, Kanagawa Investigational Site Number : 3920002, Hiroshima Investigational Site Number : 3920001, Saitama Investigational Site Number : 3920004, Tokyo Taiwan
Investigational Site Number : 1580003, Kaohsiung City Investigational Site Number : 1580001, Taichung Investigational Site Number : 1580002, Taipei